Chuan Xin Lian

Chuan Xin Lian (Herba Andrographidis) is the dried aerial parts of Andrographis paniculata (Burm. f.) Nees, an annual herbaceous plant in the family Acanthaceae (acanthus family). In the traditional TCM classification system, Chuan Xin Lian is considered extremely bitter in flavor with a cold nature. It enters the Heart, Lung, Large Intestine, and Bladder meridians, giving it a central role in formulas that address Heat-toxin accumulation, Damp-Heat patterns, and various inflammatory conditions.

Botanical description: Andrographis paniculata is an erect annual herb that grows 30–100 cm tall, with quadrangular stems that are much branched and green to dark purple in color. The leaves are opposite, petiolate or subsessile, lanceolate to ovate-lanceolate, 2–11 cm long and 0.5–3 cm wide, with an acuminate apex and an entire or slightly undulate margin. The leaf surface is glabrous and dark green on the upper side, with prominent veins on the lower surface. The plant produces small, white to pale purple flowers with purple markings on the lower lip, arranged in axillary and terminal racemes or panicles. The fruit is a linear capsule, approximately 2 cm long, containing numerous small, subquadrate, yellow-brown seeds. The entire plant has an extremely bitter taste, which is characteristic of the herb and reflects its high content of bitter diterpene lactones. The aerial parts are harvested during the flowering stage in late summer or early autumn, then dried in the shade or at low temperature.

Habitat and cultivation: A. paniculata is native to South Asia and Southeast Asia, including India, Sri Lanka, Pakistan, Thailand, and Malaysia. It has been cultivated in southern China for over a thousand years and is now widely grown in the provinces of Guangdong, Guangxi, Fujian, Yunnan, Sichuan, and Jiangsu. The plant prefers warm, humid climates and well-drained, fertile soil. It grows best in full sun to partial shade at altitudes below 1,000 meters. In traditional Chinese cultivation, seeds are sown in spring, and the herb is harvested when the plants are in full bloom, typically 3–4 months after planting. The quality of Chuan Xin Lian is highly dependent on growing conditions, with plants grown in warmer, sunnier climates generally having higher andrographolide content. Commercial cultivation is extensive in both China and India, with standardized cultivation practices aimed at maximizing the content of active diterpene lactones.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Chuan Xin Lian should have intact stems and leaves, a dark green color, and an extremely bitter taste. The pharmacopoeia sets a minimum standard of not less than 0.80% andrographolide content on a dried basis as a quality marker. Premium-grade material is characterized by its dark green leaves, slender green stems, minimal flower and fruit material, and intense bitterness. The herb should be free from mold, insect damage, discoloration, and excessive stem or root material. In addition to andrographolide, the content of dehydroandrographolide succinate and other diterpene lactones may also be measured for quality control purposes in some commercial products. The extremely bitter taste is considered an important traditional quality indicator — the more bitter the taste, the higher the quality of the herb.

In the traditional Chinese medicine theoretical framework, Chuan Xin Lian is understood in terms of its effects on specific patterns of disharmony (zheng). Because Chuan Xin Lian enters the Heart, Lung, Large Intestine, and Bladder meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving Heat-toxin accumulation and Damp-Heat.

Clearing Heat and resolving toxicity: Chuan Xin Lian is considered one of the most potent Heat-clearing and toxicity-resolving herbs in the TCM materia medica. In TCM theory, Heat-toxin patterns may manifest as high fever, sore throat, tonsillitis, mouth ulcers, toothache, skin abscesses, carbuncles, and various inflammatory conditions. Chuan Xin Lian's bitter, cold nature is believed to strongly clear Heat from multiple organ systems and resolve toxic pathogens. It is commonly used for respiratory tract infections, including pharyngitis, tonsillitis, bronchitis, and pneumonia, where it is combined with other Heat-clearing herbs such as Jin Yin Hua, Lian Qiao, and Ban Lan Gen.

Drying Dampness and clearing Damp-Heat: Chuan Xin Lian is traditionally used to clear Damp-Heat patterns, particularly those affecting the digestive system and urinary tract. In TCM theory, Damp-Heat in the Large Intestine may present as diarrhea, dysentery, abdominal pain, and tenesmus. Damp-Heat in the Bladder may manifest as urinary tract infections, painful urination, and dark, scanty urine. Chuan Xin Lian's bitter nature is believed to dry Dampness while its cold nature clears Heat, making it effective for combined Damp-Heat patterns. It is commonly combined with Huang Lian and Huang Qin for gastrointestinal Damp-Heat, and with Che Qian Zi and Bi Xie for urinary Damp-Heat.

Reducing swelling and relieving pain: Chuan Xin Lian is traditionally used for reducing swelling and relieving pain in various inflammatory conditions. Its Heat-clearing and toxicity-resolving properties are believed to reduce inflammatory swelling and alleviate pain associated with Heat-toxin patterns. It is used both internally and topically for conditions such as skin abscesses, carbuncles, boils, snake bites, and traumatic injuries with inflammation. Topically, the fresh herb may be pounded into a paste and applied to affected areas, or the dried powder may be mixed with other herbs for external application.

Clearing Lung Heat and stopping cough: Chuan Xin Lian enters the Lung meridian and is traditionally used to clear Lung Heat and stop cough associated with Heat patterns. In TCM theory, Lung Heat may present as cough with yellow or green phlegm, chest pain, fever, and a red tongue with yellow coating. Chuan Xin Lian's bitter, cold nature is believed to clear Heat from the Lung and help resolve cough and phlegm due to Heat accumulation. It is often combined with other Lung-clearing herbs such as Yu Xing Cao and Huang Qin for respiratory Heat patterns.

Classical literature references: The Ling Biao Cai Lu (Records of Gathering Herbs in Lingnan, circa 1700 CE) first recorded Chuan Xin Lian's use for "clearing Heat and resolving toxicity." The Ben Cao Qiu Yuan (Seeking the Source of Materia Medica, 1765 CE) noted its use for "all types of Heat-toxin, swelling, and pain." The Guangdong Zhong Cao Yao (Guangdong Chinese Herbal Medicine, modern) described its use for "acute bacillary dysentery, gastroenteritis, upper respiratory tract infections, and various inflammatory conditions." In modern TCM practice, Chuan Xin Lian has become one of the most widely used Heat-clearing herbs and is available in various dosage forms including tablets, capsules, and injections.

Chuan Xin Lian contains a diverse array of bioactive compounds, with the diterpene lactones being the most characteristic and well-studied class. The following overview summarizes the major chemical constituents identified in the aerial parts of Andrographis paniculata and what is currently known about them from published research.

Andrographolide: Andrographolide is the most abundant and well-studied diterpene lactone in Chuan Xin Lian, typically comprising 0.5–2.5% of the dry leaf weight. It is a bicyclic diterpene lactone with an alpha-alkylidene gamma-butyrolactone moiety that is responsible for many of its biological activities. Andrographolide has been extensively investigated for its anti-inflammatory, antimicrobial, antiviral, immunomodulatory, hepatoprotective, and cardioprotective properties. Mechanistically, andrographolide has been shown to inhibit the NF-kappaB signaling pathway, reduce pro-inflammatory cytokine production, modulate immune cell function, and exert antioxidant effects. It has also been studied for its potential anticancer properties through induction of apoptosis and inhibition of angiogenesis in various cancer cell lines. Andrographolide is the primary active constituent responsible for the herb's extremely bitter taste.

Neoandrographolide: Neoandrographolide is another major diterpene lactone in Chuan Xin Lian, present in lower concentrations than andrographolide. It is a glycoside form of andrographolide, with a glucose moiety attached at the C-19 position. Neoandrographolide has been studied for its anti-inflammatory, hepatoprotective, and immunomodulatory effects. Pre-clinical research has shown that neoandrographolide can inhibit the production of pro-inflammatory cytokines and mediators, including nitric oxide, TNF-alpha, IL-6, and prostaglandin E2. It has also been investigated for its protective effects against liver injury induced by various toxins. While generally considered less potent than andrographolide on a per-weight basis, neoandrographolide contributes to the overall pharmacological profile of the herb and may have synergistic effects with andrographolide.

14-Deoxyandrographolide: 14-Deoxyandrographolide is a minor but biologically active diterpene lactone found in Chuan Xin Lian. It lacks the hydroxyl group at position 14 that is present in andrographolide. This compound has been studied for its cardiovascular and anti-inflammatory activities. Pre-clinical research has demonstrated that 14-deoxyandrographolide has vasodilatory effects and may protect against cardiovascular injury through anti-inflammatory and antioxidant mechanisms. It has also been investigated for its potential anti-diabetic and anti-cancer effects. While present in smaller amounts than andrographolide, this compound may contribute to the herb's overall therapeutic effects, particularly in the cardiovascular system.

Andrographiside: Andrographiside is a diterpene glycoside found in Chuan Xin Lian, representing a more water-soluble form of the active diterpenes. It is the glucoside of andrographolide, with a glucose molecule attached at the C-3 position. Andrographiside has been studied for its anti-inflammatory, antioxidant, and immunomodulatory effects, though it is generally considered less potent than andrographolide. Its higher water solubility may influence its bioavailability and tissue distribution compared to the more lipophilic andrographolide. Andrographiside may serve as a prodrug form that is converted to andrographolide through intestinal or hepatic metabolism after oral administration.

Flavonoids, xanthones, and other compounds: In addition to the diterpene lactones, Chuan Xin Lian contains various other bioactive compounds including flavonoids (such as 5-hydroxy-7,8-dimethoxyflavone and other polymethoxyflavones), xanthones, phenylpropanoids, and sterols. The flavonoids contribute to the herb's antioxidant and anti-inflammatory profile. Xanthones have been investigated for their potential antimicrobial and anti-inflammatory activities. The herb also contains various trace elements, vitamins, and other secondary metabolites that may play minor roles in its pharmacological effects. The synergistic interactions between the diterpene lactones and other constituents may contribute to the overall therapeutic effects of the whole herb compared to isolated andrographolide alone.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on a combination of pre-clinical studies (animal models, in-vitro experiments) and some human clinical trials. The bioavailability and clinical significance of these compounds in whole-herb preparations require further investigation.

Chuan Xin Lian is a component in several classical and modern formulas for Heat-toxin and Damp-Heat conditions. Below are three key formulas that feature Chuan Xin Lian as a component, along with their traditional indications and the role Chuan Xin Lian plays in each composition.

The following section summarizes published pharmacological and clinical research on Chuan Xin Lian and its active compounds. While there is a substantial body of research, many findings remain inconsistent or require further validation. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Upper respiratory tract infections: Andrographis paniculata extract has been investigated in several clinical trials for the treatment of upper respiratory tract infections, including the common cold, sinusitis, and pharyngotonsillitis. A randomized, double-blind, placebo-controlled trial by Cáceres et al. (1997) found that Andrographis paniculata extract significantly reduced the severity and duration of common cold symptoms compared to placebo (PMID: 9394911). A systematic review and meta-analysis by Hu et al. (2017) evaluated 33 randomized controlled trials involving 7,175 participants and concluded that Andrographis paniculata extract appeared to be effective for relieving symptoms of upper respiratory tract infections, though the quality of evidence was rated as low to moderate due to methodological limitations in the included studies (PMID: 28895397). Another systematic review by Kligler et al. (2017) found consistent benefit across multiple trials but noted that more rigorous research is needed (PMID: 29039124). While these findings are promising, further large-scale, high-quality trials are needed to confirm the efficacy of Chuan Xin Lian for respiratory infections.

Anti-inflammatory mechanisms of andrographolide: The anti-inflammatory effects of andrographolide have been extensively studied in pre-clinical models. Wang et al. (2007) demonstrated that andrographolide inhibits NF-kappaB activation through covalent modification of the cysteine 62 residue of the p50 subunit, thereby reducing the expression of pro-inflammatory genes including TNF-alpha, IL-6, IL-1beta, and COX-2 (PMID: 17244832). Other studies have shown that andrographolide also modulates the MAPK, PI3K/Akt, and Nrf2 signaling pathways. The alpha-alkylidene gamma-butyrolactone moiety of andrographolide is considered the key pharmacophore responsible for its anti-inflammatory activity through Michael addition reactions with nucleophilic cysteine residues in target proteins. These mechanistic findings provide a molecular basis for the traditional anti-inflammatory uses of Chuan Xin Lian but have not yet been fully validated in human clinical settings.

Antiviral activity: Andrographolide and Chuan Xin Lian extracts have been studied for their potential antiviral effects against various viruses in in-vitro and animal models. Studies have reported inhibitory effects against influenza A virus, herpes simplex virus, Epstein-Barr virus, dengue virus, and various enteroviruses. The mechanisms of antiviral action appear to include direct viral inactivation, inhibition of viral replication, and modulation of host immune responses. Chen et al. (2009) reported that andrographolide inhibits dengue virus replication through suppression of NF-kappaB-dependent cytokine production (PMID: 19416736). During the COVID-19 pandemic, andrographolide was investigated as a potential therapeutic agent, with some in-vitro and observational studies suggesting potential benefits, but rigorous clinical trial data remain limited. It is important to note that most antiviral studies have been conducted in-vitro or in animal models, and the clinical relevance of these findings for human viral infections is not yet established.

Immunomodulatory effects: Chuan Xin Lian and andrographolide have been shown to modulate both innate and adaptive immune responses in pre-clinical research. Andrographolide has been reported to affect the function of various immune cells including macrophages, dendritic cells, T lymphocytes, and B lymphocytes. It has been shown to enhance the production of interferon-gamma and other Th1 cytokines while suppressing excessive pro-inflammatory responses. Iruretagoyena et al. (2020) reviewed the immunomodulatory effects of andrographolide and concluded that it exhibits a dual immunomodulatory profile — enhancing immune responses in immunocompromised states while suppressing excessive inflammation in autoimmune and inflammatory conditions (PMID: 32149604). This dual immunomodulatory effect is consistent with the traditional TCM use of Chuan Xin Lian for both clearing pathogenic factors and supporting normal immune function. However, human clinical data on the immunomodulatory effects of Chuan Xin Lian remain limited.

What the research does NOT show: Despite promising pre-clinical and some clinical signals, the research on Chuan Xin Lian and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. While some clinical trials have suggested benefits for upper respiratory tract infections, the overall quality of evidence is low to moderate, and further rigorous trials are needed. There is insufficient evidence from large-scale, randomized, placebo-controlled clinical trials to support the use of Chuan Xin Lian or andrographolide for treating viral infections, autoimmune diseases, cancer, or any other medical condition. The translation from pre-clinical findings to human clinical relevance is uncertain. This page does not endorse Chuan Xin Lian as a treatment for any condition.

Important: Research findings on Chuan Xin Lian come from a mix of pre-clinical studies, clinical trials, and epidemiological research. The evidence for most therapeutic claims remains preliminary or inconclusive. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Chuan Xin Lian is widely used in TCM practice and is generally considered to have an acceptable safety profile when used appropriately at standard doses for short durations. However, as an extremely bitter and cold herb, it carries a higher risk of adverse effects compared to milder herbs, particularly with prolonged use or in susceptible individuals. The information below reflects what is currently known from published literature, pharmacopoeial standards, and clinical experience.

Gastrointestinal effects: The most common side effects of Chuan Xin Lian are gastrointestinal, including nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. These effects are attributed to the herb's extremely bitter taste and cold nature. In TCM theory, these side effects represent damage to the Spleen-Stomach Qi from the herb's cold and bitter properties. Individuals with pre-existing gastrointestinal conditions such as peptic ulcers, gastritis, or inflammatory bowel disease may be more susceptible to gastrointestinal side effects. Taking Chuan Xin Lian with food may help reduce gastrointestinal irritation, though it may also slightly reduce the absorption of active compounds. If gastrointestinal side effects occur, the dose should be reduced or the herb discontinued.

Spleen-Stomach deficiency-cold and Qi deficiency: In traditional TCM theory, Chuan Xin Lian is extremely bitter and cold in nature. Individuals with Spleen-Stomach deficiency-cold patterns — characterized by poor appetite, abdominal distension, loose stools, cold limbs, fatigue, and a pale tongue with white coating — should use Chuan Xin Lian with extreme caution or avoid it altogether, as its cold nature may further weaken digestive function and exacerbate Cold symptoms. Similarly, individuals with Qi deficiency or Yang deficiency patterns should use Chuan Xin Lian cautiously, as prolonged use may further deplete the body's Zheng Qi (vital Qi). Long-term use of Chuan Xin Lian without professional supervision is not recommended, as it may damage the Spleen Qi and lead to chronic digestive weakness. In TCM practice, Chuan Xin Lian is typically prescribed for short courses (5-14 days) and is often combined with Qi-tonifying or Stomach-protecting herbs when used in individuals with underlying deficiency.

Pregnancy and lactation: Chuan Xin Lian is generally contraindicated during pregnancy in traditional TCM practice due to its extremely cold nature and potential effects on fetal development. Some pre-clinical studies have suggested that high doses of andrographolide may have abortifacient or embryotoxic effects, though human data are extremely limited. For these reasons, Chuan Xin Lian should be avoided during pregnancy unless specifically prescribed by a qualified TCM practitioner who can carefully weigh the risks and benefits. During lactation, Chuan Xin Lian should also be used with caution, as there is insufficient information on the excretion of its constituents into breast milk and the potential effects on nursing infants. The bitter taste of the herb may also affect the taste of breast milk.

Allergic reactions and injection safety: Allergic reactions to Chuan Xin Lian have been reported, particularly with injectable forms of the herb. Symptoms may include skin rash, itching, hives, difficulty breathing, and in rare cases, anaphylaxis. The injectable forms of Chuan Xin Lian (such as andrographolide sodium bisulfite injection) have been associated with more severe adverse reactions and are subject to strict regulation in China. Oral forms of Chuan Xin Lian are generally associated with fewer allergic reactions. Individuals with known allergies to Acanthaceae plants should avoid Chuan Xin Lian. If an allergic reaction occurs, discontinue use immediately and seek medical attention.

Drug interactions: Chuan Xin Lian has the potential to interact with several types of medications. Andrographolide and other constituents may affect the activity of hepatic cytochrome P450 enzymes (particularly CYP3A4 and CYP2C9), which could theoretically alter the metabolism of drugs processed through these pathways, including statins, calcium channel blockers, certain antidepressants, and immunosuppressants. Due to its immunomodulatory effects, Chuan Xin Lian may theoretically interact with immunosuppressive medications or immunostimulant drugs. Its anti-inflammatory properties may have additive effects when combined with NSAIDs or corticosteroids. Additionally, Chuan Xin Lian may have hypoglycemic effects and could potentially enhance the effects of diabetes medications. Its anticoagulant properties may increase bleeding risk when combined with blood-thinning medications. However, clinical data on drug interactions involving whole-herb Chuan Xin Lian in humans are limited. Consult a qualified healthcare professional before combining Chuan Xin Lian with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Chuan Xin Lian or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.